©2018 NAVINTA LLC. All rights reserved.

APPROVED PRODUCTS

Commercial product categories are diverse in the Navinta product portfolio and include an anticholinergic agent, benztropine mesylate used in the treatment of Parkinson’s disease to ribavirin, a viral RNA polymerase inhibitor, to treat children with respiratory syncytial virus.